Monday, November 03, 2025 | 10am EDT: Deconstructing OCD Through the Use of Multiple Operant Behavioral Tasks in Rodents

Researchers Identify Multi-Action Drug Candidate For Type 2 Diabetes And Bone Disease

Posted on: July 28, 2016 in News | Life Science News | Pharma News
By: Sarah Massey, M.Sc.

Related Vitals

Novo Nordisk Ignites High-Stakes Bidding War with Pfizer for Obesity Biotech Metsera

Pfizer Metsera

News October 31, 2025

Novartis Acquires Avidity Biosciences for Late-Stage Muscular Dystrophy Assets in $12B Deal

Avidity Biosciences

News October 31, 2025

MapLight Therapeutics Raises $296M in IPO to Advance CNS Drug Pipeline

MapLight Therapeutics IPO, maplight therapeutics company, maplight therapeutics, maplight therapeutics stock

News October 31, 2025

“Don’t Sleep on OSA”: Eli Lilly and Shaquille O’Neal Team Up for Sleep Apnea Awareness

Don’t Sleep on OSA

News October 30, 2025

Thermo Fisher Deepens Clinical Data and AI Footprint with $9.4B Clario Acquisition

Clario Acquisition

News October 29, 2025

Related Webinars

December 16, 2025

Enhancing Clinical Efficiency Through Master Protocol Trial Design

PPD(KarenS)_Dec16_Hero_1600x400

December 09, 2025

Managing Placebo Risk in Dermatology Trials

Dec 9th Derm Webinar

December 16, 2025

ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change

November 14, 2025

IRB & ICF Approval Simplified: 5 Key Considerations and Mistakes

SabaiGlobal_Nov14 Hero

December 03, 2025

Becoming a sponsor of choice for high-performing sites

ICON_xtalks – 3